Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

I Mab (IMAB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow I Mab's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.800 -0.010    -0.55%
16:00:00 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 88,595
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.800 - 1.830
I Mab 1.800 -0.010 -0.55%

IMAB Recent Sentiments

 
This page contains information on users’ sentiments for the I Mab stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 23, 2024 Alejandro Martínez...   1.800 0.00%
Apr 18, 2024 gabriel curcan   1.800 Apr 18, 2024 @ 1.800 0.00%
Mar 21, 2024 christian autiero   1.810 Apr 12, 2024 @ 1.810 0.00%
Mar 18, 2024 Krzysztof Dekanski   1.800 Apr 12, 2024 @ 1.810 +0.56%
Mar 18, 2024 Marlen Samidinov   1.820 Apr 12, 2024 @ 1.810 +0.55%
Mar 15, 2024 Alessandro Donno   1.800 Mar 18, 2024 @ 1.810 +0.56%
Mar 11, 2024 Bohdan zozulia   1.860 Mar 11, 2024 @ 1.860 0.00%
Mar 08, 2024 Alessandro Donno   1.830 Mar 11, 2024 @ 1.860 +1.64%
Feb 28, 2024 Alessandro Donno   1.850 Mar 04, 2024 @ 1.720 -7.03%
Feb 27, 2024 Mauro Spaziani Testa   1.850 Mar 22, 2024 @ 1.870 +1.08%
Feb 26, 2024 Andoni Ni   1.660 Mar 22, 2024 @ 1.870 +12.65%
Feb 22, 2024 Onur Aslan   1.590 Mar 15, 2024 @ 1.860 -16.98%
Feb 22, 2024 Łukasz Marcinkowski   1.600 Feb 26, 2024 @ 1.660 -3.75%
Feb 16, 2024 Daniu yyy   1.760 Feb 19, 2024 @ 1.710 -2.84%
Feb 12, 2024 Alessandro Donno   1.790 Feb 19, 2024 @ 1.710 -4.47%
Feb 09, 2024 Luka Cerjak   1.770 Feb 09, 2024 @ 1.770 0.00%
Feb 09, 2024 Francisco Javier...   1.780 Mar 01, 2024 @ 1.790 +0.56%
Feb 09, 2024 Alessandro Donno   1.770 Feb 12, 2024 @ 1.820 +2.82%
Feb 09, 2024 Ludovic De San...   1.780 Mar 01, 2024 @ 1.790 +0.56%
Feb 08, 2024 Anna Tereha   1.820 Feb 12, 2024 @ 1.820 0.00%
Feb 06, 2024 Ashok Patel   2.000 Mar 01, 2024 @ 1.790 -10.50%
Feb 06, 2024 Eriks Grauss   1.750 Feb 12, 2024 @ 1.820 -4.00%
Jan 24, 2024 alex matei   1.890 Feb 16, 2024 @ 1.710 -9.52%
Jan 19, 2024 Sigurdur Hannesson   1.520 Feb 09, 2024 @ 1.730 +13.82%
Jan 17, 2024 Franciszek Latek   1.700 Jan 17, 2024 @ 1.700 0.00%
Jan 08, 2024 Dilyan Lyubomirov   2.100 Feb 02, 2024 @ 1.800 -14.29%
Jan 04, 2024 Ha Tran Manh   2.210 Jan 26, 2024 @ 1.800 -18.55%
Jan 03, 2024 Carlos R   2.210 Jan 26, 2024 @ 1.800 -18.55%
Jan 03, 2024 Carlos R   2.210 Jan 03, 2024 @ 2.210 0.00%
Jan 03, 2024 Mariusz Hewelt   2.170 Jan 26, 2024 @ 1.800 -17.05%
Jan 02, 2024 Alessandro Donno   2.170 Jan 08, 2024 @ 2.080 -4.15%
Dec 28, 2023 Ashok Gouda   1.680 Dec 28, 2023 @ 1.680 0.00%
Dec 19, 2023 Don Antonio Lamela...   1.480 Jan 12, 2024 @ 2.050 +38.51%
Nov 02, 2023 Max Bourbon   1.600 Nov 30, 2023 @ 1.540 -3.75%
Oct 24, 2023 Artur Michal   1.230 Nov 30, 2023 @ 1.540 +25.20%
Oct 03, 2023 сергей гюмюшлю   1.270 Nov 30, 2023 @ 1.540 +21.26%
Sep 28, 2023 hlias karampinos   1.230 Nov 30, 2023 @ 1.540 +25.20%
Aug 07, 2023 Josef Hájek   2.660 Aug 07, 2023 @ 2.670 +0.38%
Jul 26, 2023 José Javier Ferreira...   2.920 Nov 30, 2023 @ 1.540 -47.26%
Jul 19, 2023 Mariusz Hewelt   3.130 Nov 30, 2023 @ 1.540 -50.80%
Jul 12, 2023 Koicho Tachev   2.800 Nov 30, 2023 @ 1.540 -45.00%
Jul 07, 2023 Koicho Tachev   2.620 Jul 12, 2023 @ 2.800 +6.87%
Jul 05, 2023 lyt hical   2.920 Nov 30, 2023 @ 1.540 -47.26%
Jun 13, 2023 Marlen Samidinov   3.240 Nov 30, 2023 @ 1.540 +52.47%
May 31, 2023 сергей гюмюшлю   3.110 Oct 02, 2023 @ 1.300 -58.20%
May 24, 2023 Remus Moldovan   3.030 Nov 30, 2023 @ 1.540 -49.17%
May 10, 2023 Alessandro Donno   3.130 Nov 30, 2023 @ 1.540 -50.80%
Apr 26, 2023 Alessandro Donno   3.000 May 09, 2023 @ 3.020 +0.67%
Apr 26, 2023 gdoc   2.990 Nov 30, 2023 @ 1.540 -48.49%
Apr 13, 2023 Alessandro Donno   3.660 Apr 17, 2023 @ 3.640 -0.55%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

IMAB Comments

Write your thoughts about I Mab
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Andrew Gordon
Andrew Gordon Dec 14, 2023 9:01PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
IMAB has potential licensing deals for at least $1.2B
Koicho Tachev
Koicho Tachev Apr 30, 2023 2:14AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
it's time to go up !
Filippo Canducci
FiloVance Mar 16, 2021 1:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
benzinga.com/analyst-ratings/analyst-color/21/03/20169471/i-mab-poised-to-capitalize-on-growing-oncology-sector-needham-says-in-bullish-initi
Filippo Canducci
FiloVance Feb 08, 2021 9:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
should be going up!!!!
mamadou cisse
mamadou cisse Feb 08, 2021 9:49AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Filippo Canducci
FiloVance Jan 04, 2021 2:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
any news here?
곽 동윤
곽 동윤 Sep 04, 2020 8:29AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
R u guys ready to invest?
곽 동윤
곽 동윤 Aug 04, 2020 9:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
China NMPA Accepts IND Application for Eftansomatropin Pivotal Trial in Pediatric Patients with Growth Hormone DeficiencyThe news about IMAB.
곽 동윤
곽 동윤 Jun 30, 2020 2:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I am waiting the news about Covid-19 treatment!!
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email